CS logo
small CS logo
Moscow City Oncology Hospital #62

Moscovskaya Oblast, Moskovskaja Oblast, Russian Federation
Hospital in Russia
д. 27, Stepanovskoye, Moscow Oblast, 143423

About Moscow City Oncology Hospital #62


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
30
Janssen Research & Development, LLC
8
Biocad
5
Eisai Inc.
2
Alaunos Therapeutics
1
City Clinical Oncology Hospital No 1
1
Daiichi Sankyo, Inc.
1
Genentech, Inc.
1
Helsinn Healthcare SA
1
Infinity Pharmaceuticals, Inc.
1
Intarcia Therapeutics
1
Total Rows: 17

Clinical Trials at Moscow City Oncology Hospital #62


During the past decade, Moscow City Oncology Hospital #62 conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 26 clinical trials were completed, i.e. on average, 63.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 13 clinical trials were completed. i.e. 162.5% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years7722771010775522111111443344664400Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
2002-06-01
2006-01-01
Completed
865
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
2005-03-01
Completed
623
Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
2006-03-01
2010-07-01
Completed
676
Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin
2007-05-01
2008-04-01
Terminated
15
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
2009-10-16
2017-01-24
Completed
596
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
2011-05-01
2014-04-01
Completed
226

Rows per page:

1–58 of 58

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Moscow City Oncology Hospital #62" #1 sponsor was "Hoffmann-La Roche" with 30 trials, followed by "Janssen Research & Development, LLC" with 8 trials sponsored, "Biocad" with 5 trials sponsored, "Eisai Inc." with 2 trials sponsored and "Alaunos Therapeutics" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Moscow City Oncology Hospital #62" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 30Hoffmann-La Roche: 30Janssen Research &Development, LLC: 8Janssen Research &Development, LLC: 8Biocad: 5Biocad: 5Eisai Inc.: 2Eisai Inc.: 2Alaunos Therapeutics: 1Alaunos Therapeutics: 1City Clinical OncologyHospital No 1: 1City Clinical OncologyHospital No 1: 1Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1Genentech, Inc.: 1Genentech, Inc.: 1Helsinn Healthcare SA: 1Helsinn Healthcare SA: 1Infinity Pharmaceuticals, Inc.: 1Infinity Pharmaceuticals, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsAstraZeneca: 1AstraZeneca: 1Daiichi Sankyo Co., Ltd.: 1Daiichi Sankyo Co., Ltd.: 1European Network ofGynaecologicalOncological Trial Groups(ENGOT): 1European Network ofGynaecologicalOncological Trial Groups(ENGOT): 1GOG Foundation: 1GOG Foundation: 1Genentech, Inc.: 1Genentech, Inc.: 1Johnson & JohnsonPharmaceuticalResearch &Development, L.L.C.: 1Johnson & JohnsonPharmaceuticalResearch &Development, L.L.C.: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1Moscow City OncologyHospital No. 62: 1Moscow City OncologyHospital No. 62: 1Moscow ClinicalScientific Center: 1Moscow ClinicalScientific Center: 1PSI CRO: 1PSI CRO: 1

Clinical Trials Conditions at Moscow City Oncology Hospital #62


According to Clinical.Site data, the most researched conditions in "Moscow City Oncology Hospital #62" are "Breast Cancer" (5 trials), "Non-Small Cell Lung Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Early Breast Cancer" (3 trials) and "Melanoma" (3 trials). Many other conditions were trialed in "Moscow City Oncology Hospital #62" in a lesser frequency.

Clinical Trials Intervention Types at Moscow City Oncology Hospital #62


Most popular intervention types in "Moscow City Oncology Hospital #62" are "Drug" (55 trials), "Biological" (5 trials), "Other" (4 trials), "Procedure" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "Carboplatin" (15 trials), "Atezolizumab" (9 trials), "Paclitaxel" (9 trials) and "Pemetrexed" (8 trials). Other intervention names were less common.

Clinical Trials Genders at Moscow City Oncology Hospital #62


The vast majority of trials in "Moscow City Oncology Hospital #62" are 44 trials for "All" genders, 8 trials for "Female" genders and 6 trials for "Male" genders.

Clinical Trials Status at Moscow City Oncology Hospital #62


Currently, there are NaN active trials in "Moscow City Oncology Hospital #62". undefined are not yet recruiting, 8 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Moscow City Oncology Hospital #62, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Moscow City Oncology Hospital #62, 3 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 44Phase 3: 44Phase 2: 10Phase 2: 10Phase 1: 3Phase 1: 3Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 27Completed: 27Active, not recruiting: 17Active, not recruiting: 17Recruiting: 8Recruiting: 8Terminated: 4Terminated: 4Unknown status: 2Unknown status: 2